Your browser doesn't support javascript.
loading
Detection of Clinically Significant Index Prostate Cancer Using Micro-ultrasound: Correlation With Radical Prostatectomy.
Callejas, Matias F; Klein, Eric A; Truong, Matthew; Thomas, Lewis; McKenney, Jesse K; Ghai, Sangeet.
Afiliação
  • Callejas MF; Toronto Joint Department of Medical Imaging, University Health Network - Mt Sinai Hospital - Women's College Hospital, University of Toronto, Toronto, Ontario, Canada.
  • Klein EA; Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH.
  • Truong M; Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH.
  • Thomas L; Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH.
  • McKenney JK; Robert J. Tomsich Pathology and of Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH.
  • Ghai S; Toronto Joint Department of Medical Imaging, University Health Network - Mt Sinai Hospital - Women's College Hospital, University of Toronto, Toronto, Ontario, Canada. Electronic address: Sangeet.Ghai@uhn.ca.
Urology ; 169: 150-155, 2022 11.
Article em En | MEDLINE | ID: mdl-35843353
ABSTRACT

OBJECTIVE:

To determine the detection of clinically significant prostate cancer (csPCa) index lesion using high resolution transrectal micro-ultrasound (MicroUS) applying PRI-MUS (Prostate Risk Identification using Micro Ultrasound) score v1.0.

METHODS:

Men who underwent radical prostatectomy following biopsy and MicroUS assessment were included. MicroUS dynamic cine loops of these patients were retrospectively reviewed by an experienced radiologist. The radiologist was aware that patients had undergone radical prostatectomy but was blinded to pathological data. Suspicious sites were assigned a PRI-MUS score. Radical prostatectomy specimens were examined with the quarter mount technique. Detection rate of csPCa index lesion [Grade Group (GG) ≥2] by MicroUS was assessed at a patient level.

RESULTS:

Twenty-five participants were included in the analysis. The median age was 65.5 years (range 56-74). Median PSA was 6.45 ng/dL (range 2-31.72). Two of 25 patients did not have csPCa (GG1 disease) on radical prostatectomy. MicroUS visualized 20/23 (87%) of the csPCa index lesions [median length 9 mm (range 1.5- 28.5)]. All identified lesions were categorized PRIMUS score 4 or 5. The 3 missed index lesions were in the transition zone [median length 10.5 mm (range 4.5-22.5)]. MicroUS missed 11 non index csPCa in 9 participants [median length 1.5 mm (range 1.5-10.5)]. Of these, 8 were GG2, 2 GG3 and 1 GG5. MicroUS identified the csPCa index lesion in all 9 of these men.

CONCLUSION:

MicroUS showed the high sensitivity (87%) in detecting index lesions in the prostate gland and identified 100% of index lesions in the peripheral zone.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Próstata / Neoplasias da Próstata Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans / Male / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Próstata / Neoplasias da Próstata Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans / Male / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article